Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3992)
All Articles published online
|
Jun 15, 2012 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Meng W, Zhu HH, Xu ZF, Cai SR, Dong Q, Pan QR, Zheng S, Zhang SZ. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. World J Gastrointest Oncol 2012; 4(6): 145-151 [PMID: 22737276 DOI: 10.4251/wjgo.v4.i6.145] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v4/i6/145.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Zeinab Deris Zayeri, Abazar Parsi, Saeid Shahrabi, Masoud Kargar, Nader Davari, Najmaldin Saki. Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03117-z
|
| 3 |
Zongwei Li, Peng Yang, Zhuoyu Li. The multifaceted regulation and functions of PKM2 in tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1846(2): 285 doi: 10.1016/j.bbcan.2014.07.008
|
| 4 |
Mallikarjuna Uppara, Franklin Adaba, Alan Askari, Susan Clark, George Hanna, Thanos Athanasiou, Omar Faiz. A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer. World Journal of Surgical Oncology 2015; 13(1): 48 doi: 10.1186/s12957-015-0446-4
|
| 5 |
Yifan Zhu, Lisheng Wang, Yanying Nong, Yunxiao Liang, Zongsheng Huang, Pingchuan Zhu, Qisong Zhang. Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma. Cancer Management and Research 2021; : 8865 doi: 10.2147/CMAR.S336322
|
| 6 |
|
| 7 |
Paul Dowling, David J. Hughes, Anne Marie Larkin, Justine Meiller, Michael Henry, Paula Meleady, Vincent Lynch, Barbara Pardini, Alessio Naccarati, Miroslav Levy, Pavel Vodicka, Paul Neary, Martin Clynes. Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer. Clinica Chimica Acta 2015; 441: 133 doi: 10.1016/j.cca.2014.12.005
|
| 8 |
Hisham K. Dabbous, Yosry Abd El-Rahman Mohamed, Runia F. El-Folly, Mohamed D. El-Talkawy, Hani E. Seddik, Dina Johar, Mohammed A. Sarhan. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer. Journal of Gastrointestinal Cancer 2019; 50(3): 442 doi: 10.1007/s12029-018-0088-1
|
| 9 |
M V Kruchinina, A A Gromov, Y I Prudnikova, V M Generalov, V N Kruchinin, V A Volodin, G V Shuvalov, O V Minin, S V Shehovtsov, S E Peltec, I V Minin. Application of ellipsometry, spr-technic and raman-spectroscopy into diagnosis of colorectal cancer. IOP Conference Series: Materials Science and Engineering 2019; 516: 012017 doi: 10.1088/1757-899X/516/1/012017
|
| 10 |
Idil Esen, William F Jiemy, Yannick van Sleen, Johan Bijzet, Daniel M de Jong, Pieter H Nienhuis, Riemer H J A Slart, Peter Heeringa, Annemieke M H Boots, Elisabeth Brouwer. Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis. Rheumatology 2022; 61(7): 3060 doi: 10.1093/rheumatology/keab814
|
| 11 |
Abdo Alnabulsi, Graeme I. Murray. Proteomics for early detection of colorectal cancer: recent updates. Expert Review of Proteomics 2018; 15(1): 55 doi: 10.1080/14789450.2018.1396893
|
| 12 |
Hongwei Chen, Hailin Zhou, Yunxiao Liang, Zongsheng Huang, Shanyi Yang, Xuancheng Wang, Zhiyong She, Zhijuan Wei, Qisong Zhang. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer. Journal of Pharmaceutical and Biomedical Analysis 2023; 234: 115582 doi: 10.1016/j.jpba.2023.115582
|
| 13 |
Ze Qian, Wendi Hu, Zhen Lv, Hua Liu, Diyu Chen, Yacong Wang, Jian Wu, Shusen Zheng. PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): 162 doi: 10.1016/j.clinre.2019.06.008
|
| 14 |
Paige Druce, Natalia Calanzani, Claudia Snudden, Kristi Milley, Rachel Boscott, Dawnya Behiyat, Javiera Martinez-Gutierrez, Smiji Saji, Jasmeen Oberoi, Garth Funston, Mike Messenger, Fiona M. Walter, Jon Emery. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis. Advances in Therapy 2021; 38(6): 3032 doi: 10.1007/s12325-021-01645-6
|
| 15 |
Amir Hossein Aalami, Ali Shahriari, Mohammad Mazaheri, Farnoosh Aalami, Amir Amirabadi, Amirhossein Sahebkar. Diagnostic accuracy of tumor M2-pyruvate kinase (tM2-PK) as a non-invasive biomarker in colorectal cancer: A systematic review and meta-analysis. Clinical Biochemistry 2023; 120: 110652 doi: 10.1016/j.clinbiochem.2023.110652
|
| 16 |
V. N. Kruchinin, M. V. Kruchinina, Ya. I. Prudnikova, E. V. Spesivtsev, S. V. Rykhlitskii, V. A. Volodin, S. V. Shekhovtsov, S. E. Pel’tek. The Use of Spectral Ellipsometry and Raman Spectroscopy in Screening Diagnostics of Colorectal Cancer. Optics and Spectroscopy 2019; 127(1): 170 doi: 10.1134/S0030400X19070142
|
| 17 |
Mahmood Khosravi, Ali Arash Anoushirvani, Zahedin Kheiri, Ali Rahbari, Ali Jadidi. The Importance of Evaluating Serum Levels of Tumor Markers M2-PK and Inhibin A in Patients Undergoing Colonoscopy. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231194492
|
| 18 |
Paul Dowling, Damian Pollard, AnneMarie Larkin, Michael Henry, Paula Meleady, Kathy Gately, Kenneth O'Byrne, Martin P. Barr, Vincent Lynch, Jo Ballot, John Crown, Michael Moriarty, Emmet O'Brien, Ross Morgan, Martin Clynes. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer. Molecular BioSystems 2015; 11(3): 743 doi: 10.1039/C4MB00384E
|
| 19 |
Yan-Jun Liu, Shu Zhang, Kang Hou, Yun-Tao Li, Zhan Liu, Hai-Liang Ren, Dan Luo, Shi-Hong Li. Analysis of Key Genes and Pathways Associated with Colorectal Cancer with Microarray Technology. Asian Pacific Journal of Cancer Prevention 2013; 14(3): 1819 doi: 10.7314/APJCP.2013.14.3.1819
|